MyPass Global is a digital workforce management system, designed to streamline safety and compliance in heavily-regulated industries. Founded in Australia in 2013, MyPass addresses a universal problem - workforce compliance tracking - by connecting workers, employers, sites and training providers in one central, web-based portal.
Fleet Space Technologies
Series C in 2023
Fleet Space Technologies is an Australian space technology company specializing in a constellation of commercial micro-satellites. The company has developed the world's first 3D printed all-metal patch antenna for space, significantly enhancing the throughput of its spacecraft. Fleet Space aims to transform critical mineral discovery, space exploration, and defense by utilizing its satellite-enabled systems and seismic array technology. Their innovative approach facilitates low-cost satellite-based solutions for Industrial Internet of Things applications, enabling clients to effectively explore for critical minerals globally and connect various celestial bodies, including Earth, the Moon, and Mars.
BiVACOR, Inc., founded in 2008 and based in Houston, Texas, specializes in the design and manufacture of centrifugal heart pumps aimed at replacing the functions of failing hearts. The company has developed an innovative artificial heart-pumping device that features a compact design with a magnetically levitated rotor situated between opposing pump casings. This advanced rotary blood pump technology is engineered to deliver the necessary cardiac output while minimizing the risks of blood-cell damage and clotting. BiVACOR's team comprises skilled engineers, medical specialists, and business executives who collaborate to enhance this groundbreaking technology. The company also maintains an international office in Brisbane, Australia, fostering a strong network to support its mission.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
Fleet Space Technologies
Debt Financing in 2022
Fleet Space Technologies is an Australian space technology company specializing in a constellation of commercial micro-satellites. The company has developed the world's first 3D printed all-metal patch antenna for space, significantly enhancing the throughput of its spacecraft. Fleet Space aims to transform critical mineral discovery, space exploration, and defense by utilizing its satellite-enabled systems and seismic array technology. Their innovative approach facilitates low-cost satellite-based solutions for Industrial Internet of Things applications, enabling clients to effectively explore for critical minerals globally and connect various celestial bodies, including Earth, the Moon, and Mars.
LegalVision
Debt Financing in 2022
LegalVision is a commercial law firm based in Pyrmont, New South Wales, established in 2012. It has carved out a significant presence in the Australian legal services market, having assisted over 50,000 businesses. The firm offers a wide range of legal services, including banking, finance, business transactions, commercial contracts, construction, franchising, employment advisory, intellectual property, media and entertainment, property leasing, and tax. LegalVision is recognized for its innovative business model and custom technology, which enhance the efficiency and quality of legal services provided to clients. The firm has garnered accolades such as NewLaw Firm of the Year and Innovator of the Year at the Australian Law Awards, underscoring its role as a leader in the industry.
Eucalyptus
Series C in 2022
Eucalyptus is a healthcare technology company founded in 2019 and based in Sydney, Australia. The company specializes in developing and managing digital healthcare brands that facilitate telehealth consultations, pharmacy delivery, and ongoing patient care. By integrating these services, Eucalyptus aims to create a seamless experience for both healthcare professionals and patients, enhancing access to medical services. Its platform serves as a foundation for building effective and connected digital healthcare solutions.
Harmoney
Debt Financing in 2021
Harmoney is an online lending platform that specializes in unsecured personal loans, offering amounts up to $70,000. Established in 2014, it has become Australasia's largest marketplace for personal loans, facilitating over $1.6 billion in loans for more than 50,000 customers in Australia and New Zealand. The platform provides a quick and entirely online application process, allowing individuals to obtain loan quotes without affecting their credit scores. Harmoney offers a diverse range of loan products, including personal, car, wedding, holiday, education, business, and home improvement loans. The company is committed to responsible lending and aims to simplify the borrowing experience through technology and big data. Recognized for its innovative approach, Harmoney has created a purpose-driven culture focused on helping individuals achieve their financial goals.
EatClub
Debt Financing in 2021
EatClub is a world first customer engagement platform that gives restaurants the control to manage demand for their tables and improve their profit margins through the use of dynamic pricing. Founded by esteemed chef Marco Pierre White, EatClub was designed by restaurateurs to help restaurants fill their tables at off-peak times by offering diners last-minute deals via the app. Our partner portfolio of over 1500 restaurants includes Sake, Rockpool Dining Group, The Meatball and Wine Bar, Bills, Ormeggio at the Spit, and many more. EatClub is operational in Sydney and Melbourne, with expansion plans to get the whole of Australia to eat out, more often.
Phocas
Venture Round in 2021
Phocas has thousands of customers across North America, the UK, Europe and Australia. They're experts in helping manufacturing, distribution and retail customers turn their company data into results. From easy-to-read dashboards, to the renowned lightning-fast grid, everything about Phocas is designed for ease-of-use. Phocas allows you to drill from high level dashboards right down into the underlying transactions. It’s not just turning data into pretty pictures, it's about seeing the data that makes your business tick.
Phocas
Debt Financing in 2020
Phocas has thousands of customers across North America, the UK, Europe and Australia. They're experts in helping manufacturing, distribution and retail customers turn their company data into results. From easy-to-read dashboards, to the renowned lightning-fast grid, everything about Phocas is designed for ease-of-use. Phocas allows you to drill from high level dashboards right down into the underlying transactions. It’s not just turning data into pretty pictures, it's about seeing the data that makes your business tick.
Kira Biotech
Series A in 2019
Kira Biotech is an Australian biotechnology company focused on developing innovative immunomodulatory compounds for treating immune system disorders. The company's lead candidate, KB312, is a first-in-class monoclonal antibody designed to selectively deplete activated immune cells, aiming to restore immune balance by inducing tolerance. Kira Biotech is currently advancing KB312 through preclinical development and phase 1 clinical trials, supported by a team of experienced drug development professionals, including Dr. Dan Baker, a prominent rheumatologist and immunologist. The company has successfully secured venture capital funding to support its research and development efforts.
Edrolo
Debt Financing in 2019
At Edrolo, our mission is simple: to improve education. We're an Australian, venture-backed edtech startup with global ambitions. We are all passionate about our mission and building a culture where we can all do the best work of our lives. Our belief is that all students should have access to the greatest teachers, people who bring subjects to life and inspire learning and passion. We believe students should have access to this regardless of where they live or what school they attend. Additionally, all schools should have access to powerful data to drive school improvement, which is accessible via our platform.
Phocas
Venture Round in 2018
Phocas has thousands of customers across North America, the UK, Europe and Australia. They're experts in helping manufacturing, distribution and retail customers turn their company data into results. From easy-to-read dashboards, to the renowned lightning-fast grid, everything about Phocas is designed for ease-of-use. Phocas allows you to drill from high level dashboards right down into the underlying transactions. It’s not just turning data into pretty pictures, it's about seeing the data that makes your business tick.
BiVACOR
Venture Round in 2018
BiVACOR, Inc., founded in 2008 and based in Houston, Texas, specializes in the design and manufacture of centrifugal heart pumps aimed at replacing the functions of failing hearts. The company has developed an innovative artificial heart-pumping device that features a compact design with a magnetically levitated rotor situated between opposing pump casings. This advanced rotary blood pump technology is engineered to deliver the necessary cardiac output while minimizing the risks of blood-cell damage and clotting. BiVACOR's team comprises skilled engineers, medical specialists, and business executives who collaborate to enhance this groundbreaking technology. The company also maintains an international office in Brisbane, Australia, fostering a strong network to support its mission.
Prota Therapeutics
Series A in 2017
Prota Therapeutics is an Australian, proprietary limited, privately-held biotech company established in 2016 to develop and commercialize novel combination probiotic allergen oral immunotherapy treatments. Prota holds an exclusive license to the patented probiotic food immunotherapy technology, developed at the MCRI. Series A funding of AUD $15m was secured from OneVentures, a leading Australian venture capital investment firm (OneVentures' Healthcare Fund III) – including $5M from the Australian Commonwealth Government Biomedical Translation Fund – as well as private investment. This has enabled Prota to advance their clinical program, develop scalable cGMP product manufacturing processes, and initiate discussions with regulatory agencies in the lead up to a planned large-scale pivotal Phase 3 efficacy and safety study for the PRT100 peanut allergy treatment.
Smart Sparrow
Series C in 2017
Smart Sparrow operates an innovative e-learning platform that allows educators and organizations to create interactive and adaptive courseware across various subjects, such as digital literacy, computer science, engineering, finance, and soft skills. Founded in December 2010 by Ariel Shoham, Dror Ben-Haim, Shaowei Ho, and Zack Belinson, the company is headquartered in Surry Hills, Australia, with an additional office in San Francisco, California. The platform features a user-friendly, drag-and-drop authoring tool accessible through any web browser, enabling educators to build customized courses, define personalized learning paths for students, and collaborate in real-time. Additionally, Smart Sparrow provides pre-made templates to streamline the course creation process, serving a diverse range of institutions both locally and internationally.
Find-Me Technologies Pty
Venture Round in 2015
Find-Me Technologies is the creator of Carers Watch, an emergency alert system platform. The all new Carers Watch protects your loved ones and those you care for. The Carers Watch can receive incoming calls, from any landline or mobile phone, has a Global Positioning System that can monitor the location of the wearer and an alert button that can be put through to our partners specialist monitoring centres. Personal emergency alarms have been large and normally limited to working around the home. The Find-me Carers Watch is lightweight and can be worn the same as an everyday watch. It can be adapted to be worn as a brooch or pendant, and a secure strap is available making it suitable for all needs. The Find-me Carers Watch is a wrist watch that not only tells the time, but also incorporates the capabilities of a mobile phone, a panic alert (with two way voice communication), a tracking system, a fall sensor and is water resistant so it can be worn in the shower or rain. It will work anywhere there is mobile phone coverage (including Telstra NextG) and is 3G compatible. For monitoring you can connect it via our easy to use web interface to alert family and friends and is available through our partners Tunstall in Australia and New Zealand to be monitored by their specialist 24/7 response centres. The watch is also easily changed to a duress alert with one way communication to the call centres for people that work alone or in dangerous environments.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
Hatchtech
Venture Round in 2013
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.
Hatchtech
Venture Round in 2012
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.
Vaxxas is a biotechnology company based in Brisbane, Australia, that specializes in developing a needle-free vaccination technology aimed at transforming vaccine delivery. The company's innovative system employs an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This approach allows for direct deposition of vaccines among a dense concentration of immune cells in the skin. Additionally, Vaxxas utilizes proprietary dry-coating technology to minimize or eliminate the need for refrigeration during the storage and transport of vaccines, thereby alleviating the logistical challenges associated with maintaining the cold chain. Founded in 2011, Vaxxas aims to enhance global vaccination efforts through its novel delivery system.
Smart Sparrow
Series A in 2011
Smart Sparrow operates an innovative e-learning platform that allows educators and organizations to create interactive and adaptive courseware across various subjects, such as digital literacy, computer science, engineering, finance, and soft skills. Founded in December 2010 by Ariel Shoham, Dror Ben-Haim, Shaowei Ho, and Zack Belinson, the company is headquartered in Surry Hills, Australia, with an additional office in San Francisco, California. The platform features a user-friendly, drag-and-drop authoring tool accessible through any web browser, enabling educators to build customized courses, define personalized learning paths for students, and collaborate in real-time. Additionally, Smart Sparrow provides pre-made templates to streamline the course creation process, serving a diverse range of institutions both locally and internationally.
Hatchtech
Venture Round in 2010
Hatchtech is an Australian company focused on developing innovative pest control solutions through its proprietary technology platform. The company's patented approach targets the egg hatch of pest species, effectively disrupting their lifecycle with a novel mode of action. Hatchtech's technology is designed to address various invertebrate pests, including ectoparasites such as head lice, as well as pests affecting animals, crops, and the built environment. Their flagship product offers a single-dose treatment that eliminates both head lice and their eggs in one application, providing an effective solution for infestations.